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An antisense microwalk reveals critical role of an intronic position linked
to a unique long-distance interaction in pre-mRNA splicing
Abstract
Here we report a novel finding of an antisense oligonucleotide (ASO) microwalk in which we examined the
position-specific role of intronic residues downstream from the 5′ splice site (5′ ss) of SMN2 exon 7, skipping
of which is associated with spinal muscular atrophy (SMA), a leading genetic cause of infant mortality. Our
results revealed the inhibitory role of a cytosine residue at the 10th intronic position (10C), which is neither
conserved nor associated with any known splicing motif. Significance of 10C emerged from the splicing
pattern of SMN2 exon 7 in presence of a 14-mer ASO (L14) that sequestered two adjacent hnRNP A1 motifs
downstream from 10C and yet promoted SMN2 exon 7 skipping. Another 14-mer ASO (F14) that
sequestered both, 10C and adjacent hnRNP A1 motifs, led to a strong stimulation of SMN2 exon 7 inclusion.
The inhibitory role of 10C was found to be tightly linked to its unpaired status and specific positioning
immediately upstream of a RNA:RNA helix formed between the targeting ASO and its intronic target.
Employing a heterologous context as well as changed contexts of SMN2 intron 7, we show that the inhibitory
effect of unpaired 10C is dependent upon a long-distance interaction involving downstream intronic
sequences. Our report furnishes one of the rare examples in which an ASO-based approach could be applied
to unravel the critical role of an intronic position that may not belong to a linear motif and yet play significant
role through long-distance interactions.
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ABSTRACT
Here we report a novel finding of an antisense oligonucleotide (ASO) microwalk in which we examined the position-specific
role of intronic residues downstream from the 59 splice site (59 ss) of SMN2 exon 7, skipping of which is associated with spinal
muscular atrophy (SMA), a leading genetic cause of infant mortality. Our results revealed the inhibitory role of a cytosine
residue at the 10th intronic position (10C), which is neither conserved nor associated with any known splicing motif.
Significance of 10C emerged from the splicing pattern of SMN2 exon 7 in presence of a 14-mer ASO (L14) that sequestered two
adjacent hnRNP A1 motifs downstream from 10C and yet promoted SMN2 exon 7 skipping. Another 14-mer ASO (F14) that
sequestered both, 10C and adjacent hnRNP A1 motifs, led to a strong stimulation of SMN2 exon 7 inclusion. The inhibitory role
of 10C was found to be tightly linked to its unpaired status and specific positioning immediately upstream of a RNA:RNA helix
formed between the targeting ASO and its intronic target. Employing a heterologous context as well as changed contexts of
SMN2 intron 7, we show that the inhibitory effect of unpaired 10C is dependent upon a long-distance interaction involving
downstream intronic sequences. Our report furnishes one of the rare examples in which an ASO-based approach could be
applied to unravel the critical role of an intronic position that may not belong to a linear motif and yet play significant role
through long-distance interactions.
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INTRODUCTION
Alternative splicing is an essential process in the generation
of protein diversity and has been a major contributory
force to genome evolution (Xing and Lee 2007). Current
estimates suggest that 95%–100% of human genes with two
or more exons are alternatively spliced affecting all major
aspects of cellular metabolism (Nilsen and Graveley 2010).
Splicing is catalyzed by a spliceosome that represents one
of the most complex macromolecular machines known
(Nilsen 2003; Matlin and Moore 2007). Control of alter-
native splicing rests on nonspliceosomal factors that bind
to pre-mRNA sequences called exonic splicing enhancers
(ESEs) or intronic splicing enhancers (ISEs) and exonic
splicing silencers (ESSs) or intronic splicing (ISSs) (Lin and
Fu 2007; Martinez-Contreras et al. 2007; David and Manley
2008). Enhancer and silencer motifs promote or suppress
splice-site (ss) selection, respectively. Methods to identify
splicing motifs are continuing to evolve (Chasin 2007;
Singh 2007a; Hertel 2008; Wang and Burge 2008; Yu et al.
2008). An additional regulatory role is provided by RNA
structures that enforce accessibility to splicing elements, as
well as bring two distantly located cis-elements in close
proximity (Graveley 2005; Buratti et al. 2007; Singh et al.
2007; Shepard and Hertel 2008; Warf et al. 2009). Unravel-
ing the mechanism by which splicing factors, RNA regu-
latory sequences, and structural motifs coordinate to
regulate alternative splicing is an area of growing interest
for evolving strategies to cure many human diseases asso-
ciated with defective splicing (Garcia-Blanco 2006; Cooper
et al. 2009; Tazi et al. 2009; Ward and Cooper 2010).
Despite a tremendous progress in our understanding of
pre-mRNA splicing, validation of splicing motifs in the
context of an endogenous gene has remained a daunting
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task. Antisense oligonucleotide (ASO)-based approaches
offer an extraordinary potential to address this issue with
additional implication to therapy of human diseases (Hua
et al. 2008; Bauman et al. 2009). Refinements of ASO-based
strategies have capability to provide information regarding
the accessibility and the role of certain regions within RNA
sequence. For example, ASO scanning arrays have been
employed to probe alternative folding of RNA sequences
(Ooms et al. 2004). The most exciting future application of
an ASO-based approach includes identification of the
critical role of an individual residue in pre-mRNA splicing
using endogenous context. Such studies would address the
role of the nonlinear motifs with implications to high-order
interactions and structural rearrangements.
Humans have two nearly identical copies of the Survival
Motor Neuron (SMN) gene: SMN1 and SMN2 (Lefebvre
et al. 1995). The two SMN genes code for identical proteins;
however, SMN2 predominantly generates a short transcript
due to skipping of exon 7, producing a truncated SMN that
is highly unstable (Vitte et al. 2007). The inability of SMN2
to compensate for the loss of SMN1 results in spinal mus-
cular atrophy (SMA), a debilitating disease of children and
infants (Wirth et al. 2006). Since SMN2 is almost univer-
sally present in SMA patients, correction of SMN2 exon 7
splicing holds the promise for cure. Due to anticipated tar-
get specificity, a large number of studies have focused on
ASO-based approaches to restore SMN2 exon 7 inclusion
(Bauman et al. 2009). Among these studies, our earlier re-
ported intronic splicing silencer N1 (ISS-N1) has emerged
as a leading target in a systematic antisense microwalk
(Singh et al. 2006; Hua et al. 2008). Consistently, a recent
report has independently confirmed the high therapeutic
potential of ISS-N1 by demonstrating that blocking ISS-N1
with an ASO substantially elevated the SMN levels in brain
of SMA mice (Williams et al. 2009).
ISS-N1 is a mixed composition sequence spanning from
the 10th to 24th positions of intron 7 (Fig. 1A; Singh et al.
2006). Due to its strategic location and strong negative
impact, ISS-N1 has been termed as the master checkpoint
(Buratti et al. 2006). The 15-nucleotide (nt)-long ISS-N1
harbors two putative hnRNP A1 motifs that have been
proposed to be responsible for its inhibitory impact
(Fig. 1A; Hua et al. 2008). Using an ultra-refined antisense
microwalk, we have recently shown that ISS-N1 overlaps
with an 8-nt-long GC-rich sequence spanning from the
seventh to 14th position of intron 7 (Fig. 1A; Singh et al.
2009). We have also shown that sequestering of this GC-
rich sequence with an 8-mer ASO fully restores SMN2 exon
7 inclusion in SMA patient cells (Singh et al. 2009). In-
terestingly, the stimulatory effect of the 8-mer ASO comes
without full sequestration of any of the validated hnRNP
A1 binding sites. Thus, our results open a possibility of the
role of an additional negative element and/or structural
motif associated with the GC-rich sequence in the vicinity
of the 59 ss. We have earlier reported the inhibitory role of a
RNA structure (terminal stem–loop 2 or TSL2) sequester-
ing the 59 ss of SMN2 exon 7 (Singh et al. 2007). It remains
to be seen if a factor interacting with TSL2 makes a sec-
ondary contact with the downstream GC-rich sequence or
vice versa.
Given the large number of ASOs tested (against ISS-N1),
ISS-N1 stands out among other splicing-correcting antisense
targets reported thus far. Nevertheless, not all size combi-
nations of ASOs targeting ISS-N1 and its neighboring
sequences have been examined. Consequently, the published
results do not address the role of specific residues that fall
beyond the traditional definition of motifs associated with
the known splicing factors. Here we take advantage of an
additional antisense microwalk to reveal the critical role of a
cytosine residue at the 10th position of human SMN2 intron
7 in conferring the nature of the antisense response. We refer
this residue as 10C hereafter. 10C represents the first residue
of ISS-N1 but does not belong to any of the known motifs,
including hnRNP A1 (Fig. 1A). Our study revealed a rare
finding in which two identical size ASOs whose targets
differed by a single nucleotide (one ASO sequestered 10C,
whereas other did not) produced an opposite effect on
SMN2 exon 7 splicing. We confirmed that unsequestered 10C
plays a strong negative role when combined with an ASO
targeting a 14-nt sequence immediately downstream from
10C. We also show that the inhibitory effect of unsequestered
10C is dependent upon a long-distance interaction involving
downstream intronic sequences. Our findings underscore
the potential of an ASO-based approach in unraveling the
paramount significance of a single intronic nucleotide due to
its location relative to other splicing cis-elements within an
entire intron.
RESULTS
Identification of a master position within
the core of the antisense target
Substantial evidence and independent validations confirm
that ISS-N1 is an ideal target for an ASO-mediated cor-
rection of aberrant splicing associated with a major genetic
disease (Singh et al. 2006, 2009; Hua et al. 2008; Williams
et al. 2009). Based on a stimulatory effect of ASOs targeting
ISS-N1 and the GC-rich sequence, we have established that
the first five residues of ISS-N1 constitute the core of
antisense target (Singh et al. 2009). 10C occupies the first
position of this core and is strategically located in the
middle of the GC-rich sequence (Fig. 1). The significance
of 10C emerges from the fact that it may participate in
high-order interaction because it does not fall within
the confines of the recently described hnRNP A1 motifs
proposed to be a cause for the negative effect associated
with ISS-N1 (Hua et al. 2008; Singh et al. 2009).
To further examine the role of 10C as an integral part of the
antisense target, we performed an additional ultra-refined
Singh et al.
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antisense microwalk. We used ASOs of
varying sizes that blocked different por-
tions of ISS-N1 with or without seques-
tering 10C. Of note, since ISS-N1 is a
15-nt-long element, we confined our com-
parison of antisense effect to 15-mer
or shorter ASOs (Anti-N1 being the
only exception). Annealing positions of
ASOs are diagrammatically shown in
Figure 1B. Sequences of all ASOs used
in this study are given in Table 1. For the
sake of simplicity we used an antisense
nomenclature comprised of a letter(s) fol-
lowed by a number that represents the
size of an ASO. F series ASOs possess
the identical 39 ends with the first posi-
tion of ISS-N1 being complementary to
the 39-terminal nucleotides of ASOs. L
series ASOs possess the identical 59 ends
with the last position of ISS-N1 being
complementary to the 59-terminal nucle-
otides of ASOs. M series ASOs block se-
quences in the middle of ISS-N1. Other
ASOs containing UP and DN letters
sequester residues upstreamof and down-
stream from ISS-N1, respectively. Here,
we performed antisense screening at a rel-
atively low ASO concentration of 20 nM.
Our earlier reported ASOs that seques-
tered 10C served as positive controls (Fig.
1B, green bars).
As shown in Figure 1C, ASOs that did
not sequester 10C failed to produce any
stimulatory response on SMN2 exon 7
inclusion and in some instances even
caused an increase in SMN2 exon 7 skip-
ping. The most striking example was
L14, particularly when the effect of this
ASO was compared with the effect of
F14. Note that both ASOs are 14-nt
long, the GC content of their targets is
the same, and their annealing positions
differ by only 1 nt, 10C. Yet F14 and
L14 produce opposite effects on exon 7
splicing: F14 that sequestered 10C effi-
ciently restored SMN2 exon 7 inclusion,
while L14 that did not block 10C in-
creased exon 7 skipping (Fig. 1C). An-
tagonistic effects of F14 and L14 were
verified by three different batches of
ASOs synthesized at different times. Also,
we performed experiments at various
concentrations ranging from 1 nM to
1 mM. Stimulatory effect of F14 increased
with the increasing concentrations of
FIGURE 1. An ultra-refined antisense microwalk reveals the significance of a cytosine residue
at the 10th position (10C) of SMN2 intron 7. (A) Diagrammatic representation of cis-elements
at the 59 end of SMN2 intron 7. ISS-N1 is highlighted in yellow with all but the first nucleotide
shown in red. Two hnRNP A1 motifs are indicated as described by Hua et al. (2008). GC-rich
sequence is highlighted in green (Singh et al. 2009). Numbering of nucleotides starts from the
first position of SMN2 intron 7. The location of 10C is marked by an arrow. (B) Diagrammatic
representation of ASOs and their annealing positions relative to ISS-N1 region. Numbering of
nucleotides starts from the first position of intron 7. Boundaries of ISS-N1 are demarcated.
The first ISS-N1 residue, 10C, is highlighted in blue. The GC-rich sequence (Singh et al. 2009)
is highlighted in green. The core sequence of the antisense target is highlighted in yellow. ASOs
are shown as horizontal bars. Green bars represent ASOs that promote SMN2 exon 7 inclusion
(exon 7 skipping is #45%). The intensity of green color reflects the strength of ASO
stimulatory effect. Gray bars represent ASOs that have no effect on SMN2 exon 7 inclusion.
Pink bars represent ASOs that promoted SMN2 exon 7 skipping (exon 7 skipping is $55%).
To emphasize that L14 caused the most dramatic increase in exon 7 skipping, it is shown as
a dark pink bar. (C) Splicing pattern of endogenous SMN2 after treatment with ASOs shown in
panel B. SMA type I patient fibroblasts (GM03813) were treated with 20 nM of different ASOs
and the total RNA for in vivo splicing assay was isolated 24 h post-transfection. The upper
band corresponds to exon 7–included product; the lower band corresponds to exon 7–skipped
product. The percentage of exon skipping was calculated from the total value of exon-included
and exon-skipped products. The values represent mean of three independent experiments. The
standard deviations were <5% of mean. The effect of F14 and L14 are highlighted with a green
and red box, respectively. (D) Splicing pattern of endogenous SMN2 after treatment with 50
nM of indicated ASOs. The chemistry of the ASOs used is shown on the right. In vivo splicing
assays were performed and analyzed as described in panel C. The values represent mean of
three independent experiments. The standard deviations were <5% of mean.
Long-distance interaction in alternative splicing
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F14, whereas the inhibitory effect of L14 increased with the
increasing concentrations of L14 (data not shown). Of note,
L14 sequestered both hnRNP A1 motifs within ISS-N1 and
yet promoted SMN2 exon 7 skipping. Other short ASOs that
did not sequester 10C had less pronounced negative effects.
For example, L13 and M13 that are only 1 nt shorter than
L14 showed substantially reduced if any negative effects on
SMN2 exon 7 splicing. Similar results were observed with
M12F and M12L that annealed to the 12-nt-long sequences in
the middle of ISS-N1. We also tested 15-mer ASOs that did
not sequester 10C but targeted sequences immediately down-
stream from 10C. These 15-mer ASOs produced inhibitory
response albeit at higher concentrations (data not shown).
Next, we wished to verify that the antagonistic effects of
F14 and L14 on splicing of SMN2 exon 7 were not specific
to the chemistry of ASOs. Note that in our ultrarefined
microwalk described above, the ASOs had uniformphosphor-
othioate backbone and 29-O-methyl modifications (Fig. 1D).
For comparison, we chose F14 and L14 with locked nucleic
acid (LNA) chemistry in which an extra-bridge that connects
29-oxygen and 49-carbon of ribose sugar is added (Fig. 1D).
LNAs display unprecedented hybridization affinity toward
complementary single-stranded RNA and have been widely
used in a variety of applications (Veedu and Wengel 2009).
In LNAs used in our experiments, we also replaced uracyl
residues with thymidine residues. Such replacement has
a potential to improve base pairing with adenosine residues.
To increase the intracellular stability of LNAs,we incorporated
uniform phosphorothioate backbone. LNAs corresponding
to F14 and L14 were named as F14LNA and L14LNA,
respectively. As shown in Figure 1D, F14LNA and L14LNA
retained their characteristic antagonistic effects. These results
validated the fact that sequestering of 10C is essential for
producing the stimulatory response irrespective of the chem-
istry of ASO. In addition, our results showed that inhibitory
effect of unsequestered 10C does not depend on the chemistry
of the duplex formed between an ASO and its ISS-N1 target.
Antisense effect is specific to base paring with target
Having discovered that two antisense targets differing by
a single nucleotide could produce antagonistic effect upon
annealing to their cognate ASOs, we next examined the
efficacy and specificity of these ASOs using SMN2minigene
system. For this, HeLa cells were cotransfected with the
minigene (0.1 mg) and an ASO of interest (50 nM), and
the effect on splicing was assessed by RT-PCR. To avoid the
off-target effect, we deliberately chose a lower range of
minigene and ASO concentrations that we have determined
to be optimum for modulation of SMN2 exon 7 splicing
(Singh et al. 2009). As shown in Figure 2A, the antisense
effect on splicing of SMN2 minigene was consistent with
the results for the endogenous SMN2 in SMA patient fi-
broblasts: F14 increased exon 7 inclusion, while L14 in-
creased exon 7 skipping. These results validate the necessity
of sequestration of 10C for the stimulatory response of
ASOs targeting ISS-N1. Our results also suggest that se-
quences upstream of exon 6 do not modulate the response
of ASOs targeting ISS-N1. When F14 and L14 were mu-
tated giving rise to ASOs we called F14comp and L14comp,
their effect on SMN2 exon 7 splicing was obviated (Fig.
2A). These results suggest that the positive effect of F14 and
negative effect L14 on splicing of exon 7 are dependent on
ASO base pairing with their respective target sites.
To further validate that the opposite effects of F14 and
L14 are not due to interactions with nonspecific targets, we
performed a key experiment in which ASOs were cotrans-
fected with our earlier described mutant minigene, SMN2/
I7-08. This minigene has C-to-A and U-to-G substitutions at
the fifth and the seventh positions of ISS-N1, respectively.
We have shown that these substitutions have capability to
weaken the RNA:RNA duplex formed between Anti-N1 and
ISS-N1 (Singh et al. 2006). Consistently, both F14 and L14
lost their respective antisense effects when cotransfected with
SMN2/I7-08 (Fig. 2B), confirming their target specificity.
At the same time, F14comp and L14comp, which showed
perfect complementarity with the mutated ISS-N1 within
SMN2/I7-08, produced the respective antisense effect similar
to the outcome of F14 and L14 sequestration of the wild-
type ISS-N1 (Fig. 2B). These results also underscore that the
inhibitory effect of untargeted 10C is not linked to the se-
quence of duplex formed between an ASO and its target
within ISS-N1 region.
Site-specific mutations confirm the negative
impact of unpaired 10C
We next wished to investigate a possible mechanism behind
the negative effect of L14 on SMN2 exon 7 splicing. We
TABLE 1. Sequences of ASOs used
Singh et al.
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began addressing this issue by employing a SMN2 mutant
minigene (SMN2D64) in which 10C was deleted bringing
the target of L14 1 nt closer to the 59 ss. As shown in Figure
3A, the deletion of 10C somewhat increased exon 7 skipping
compared with the wild-type SMN2, indicating that the
negative effect of ISS-N1 could be retained without 10C.
Interestingly, when cotransfected with SMN2D64, L14
showed a strong stimulatory response on exon 7 inclusion
(Fig. 3A). This result validated the inhibitory nature of
unsequestered 10C in the context of the L14:target duplex
(L14-duplex) and underscored a rare finding that deletion
of a single intronic position upstream of a target sequence
could reverse the impact of antisense response. Interest-
ingly, F14 maintained its stimulatory effect in SMN2D64
despite a 1-nt overhang at the 39 end due to the deletion
of 10C. However, improvement of exon 7 inclusion in the
presence of F14 was milder than the one produced by L14,
probably due to the fact that the RNA:RNA duplex formed
by L14 and its target was longer by 1 nt.
To further confirm that the inhibitory effect of L14 is
due to untargeted 10C in the context of L14-duplex, we
used 591U-F15. This ASO is identical to L14 except it has
an additional uracyl residue added at its 39 end. Note that
this residue does not base pair with 10C but is capable of ste-
rically preventing the accessibility of 10C (Fig. 3B). As shown
in Figure 3B, 591U-F15 completely overcame the inhibitory
response of L14. However, it was unable
to produce a stimulatory response since
it did not effectively sequester 10C.
To test whether the inhibitory effect of
L14-duplex is specifically linked to the
type of residue at the 10th intronic po-
sition, we used SMN2/64A minigene in
which 10C residue was replaced with an
adenosine residue (10A). This mutation
did not change the splicing pattern of
SMN2 (Fig. 3B), allowing more accurate
comparison of the antisense response
with and without the sequestration of
the 10th intronic nucleotide. Surpris-
ingly, L14 produced a strong stimulatory
effect in the context of 10A, confirming
that the inhibitory effect of L14-duplex
in the wild-type context is solely linked
to an untargeted cytosine residue at the
10th intronic position. Consistent with
the neutral role of the unpaired 10A,
ASOs such as F15, F14, and 1DN15 also
produced stimulatory effect on exon 7
inclusion in SMN2/64A minigene. The
effects of these ASOs were similar to
591U-F15 that sequestered the 10A (Fig.
3B).
Effect of the immediate context
on the antisense response
In order to examine the role of the immediate context of
target sequence on the antisense response, we used our
previously described SMN2 minigene mutants (Singh et al.
2006). In SMN2/5A and SMN2/5G five adenosine and
guanosine residues were inserted before ISS-N1, respec-
tively. Such arrangement will place 10C away from the 59 ss
and alter the nature of a presumptive long-distance and/or
short-distance interactions that are specific to a nucleotide
located at a particular position. When transfected in HeLa
cells, SMN2/5A and SMN2/5G showed somewhat less skip-
ping of exon 7 compared with the wild-type SMN2 mini-
gene (Fig. 4B). Upon treatment with F14, both SMN2/5A
and SMN2/5G showed increased exon 7 inclusion, suggest-
ing that the effect of F14 is exclusively based on the
blocking of a linear cis-element comprised of two putative
hnRNP A1 binding sites. Our results also confirmed that
the effect of F14 is not sensitive to the precise location of
target site with respect to the 59 ss. On the other hand, L14
produced a decreased negative effect, suggesting that a
combination of unsequestered 15C and L14-duplex is less
inhibitory than a combination of unsequestered 10C and
L14-duplex. Overall our results support that relative posi-
tioning of an antisense target with respect to the 59 ss may
FIGURE 2. Effect of ASOs are specific to their targets. (A) Diagrammatic representation of the
target area in intron 7 of SMN2 minigene. ISS-N1 is highlighted in light gray. Numbering of
nucleotides starts from the first position of intron 7. The location of 10C is marked by an
arrow. The sequences of four ASOs and their annealing positions in ISS-N1 region are shown.
Mutations are indicated in white letters and highlighted in black. Effect of ASOs on splicing of
SMN2 minigene is shown on the right. HeLa cells were cotransfected with 50 nM of a given
ASO and 0.1 mg of SMN2 minigene. Splicing was determined 24 h after transfection. The
percentage of exon 7 skipping was calculated as described in Figure 1C. (B) Diagrammatic
representation of the target area in intron 7 of SMN2/I7-08 minigene. ISS-N1 is highlighted in
gray. Numbering of nucleotides starts from the first position of intron 7. Location of 10C is
marked by an arrow. Sequences of four ASOs and their annealing positions are shown.
Mutations in ISS-N1 area as well as in the ASOs are indicated in white letters and highlighted
in black. Effect of the ASOs on splicing of SMN2/I7-08 minigene is shown on the right. In vivo
splicing assays were performed and analyzed as described in panel A.
Long-distance interaction in alternative splicing
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be important for determining the impact of an unseques-
tered residue preceding an RNA:RNA duplex formed be-
tween the target and an ASO.
To further understand the impact of the local context on
the antisense response, we used N1D30-34 and N1D25-34
minigenes in which five and 10 residues were deleted
immediately downstream from ISS-N1, respectively (Fig.
4A). These deletions are likely to break any secondary
structure overlapping ISS-N1. When transfected in HeLa
cells, transcripts derived from both of the above mutants
displayed increased exon 7 skipping (Fig. 4B). In both of
these mutants, F14 and L14 produced strong stimulatory
and inhibitory effect, respectively. Since these mutants retain
the relative positioning of ISS-N1 with respect to the 59 ss,
the antisense response was very similar
to the one in the wild-type context.
These results also suggest that the in-
hibitory effect of the combination of an
untargeted 10C and the downstream L14-
duplex might not be affected by the se-
quences immediately downstream from
ISS-N1. However, our results do not rule
out the role of further downstream
intronic sequences that may interact with
the untargeted 10C during the catalytic
core formation.
Effect of the heterologous context
on the antisense response
Studies in a heterologous system provide
valuable information regarding portabil-
ity of a cis-element in question. Linear
cis-elements are easily portable in a het-
erologous context, whereas complex cis-
elements involving long-distance inter-
actions are generally not portable. We
have previously shown that ISS-N1 is a
portable cis-element because its insertion
at the identical location within intron 6
of Caspase 3 (Casp3) minigene promotes
skipping of Casp3 exon 6 (Singh et al.
2006). Indeed, when transfected in HeLa
cells, Casp3ISS-N1 minigene showed
43% of Casp3 exon 6 skipping compared
with 19% observed in Casp3Avr mini-
gene that lacks ISS-N1 (Fig. 5A,B). 39-
Cluster is another negative element lo-
cated upstream of the 59 ss of SMN2
exon 7 (Singh et al. 2004a). Interestingly,
insertion of this element at the similar
location relative to the 59 ss (3 nt up-
stream of the exon/intron junction) (Fig.
5A) in Casp3 exon 6 (Casp3-39Cl mini-
gene) caused moderate increase in skip-
ping of this exon (Fig. 5B). When both 39-Cluster and ISS-
N1 were inserted in Casp3 minigene (Casp3N1Cl mutant)
(Fig. 5A), skipping of Casp3 exon 6 increased to 90% (Fig.
5B). Note that in Casp3N1Cl mutant we tried to recreate
‘‘SMN2’’ arrangement of ISS-N1 and 39-Cluster relative to
each other and the 59 ss. For this purpose ISS-N1 and 39-
Cluster were inserted 9 nt and 3 nt downstream from and
upstream of the 59 ss of Casp3 exon 6, respectively (Fig. 5A).
Since Casp3N1Cl showed the highest amount of exon
skipping (Fig. 5B), we decided to use this minigene to test
the effect of ISS-N1 targeting by F14 and L14 on splicing
of the ‘‘heterologous’’ exon. As shown in Figure 5C,
when Casp3N1Cl was cotransfected with F14, inclusion of
Casp3 exon 6 increased significantly. Surprisingly, L14 also
FIGURE 3. Sequestration of 10C decides the outcome of antisense response. Numbering of
nucleotides starts from the first intronic position. ISS-N1 sequence is highlighted in gray. The
first C residue in ISS-N1 is marked as 10C. (A) Diagrammatic representation of the 59 portion
of intron 7 of SMN2 minigene and its mutant, SMN2/D64. The location of 10C and its deletion
are indicated. Effect of ASOs on splicing of wild-type and mutated SMN2 minigene is shown
on the right. Cotransfections and analyses were done as in Figure 2A. (B) Diagrammatic
representation of wild-type and mutated ISS-N1 targeted by different ASOs. Sequences of
ASOs and their base pairing with the corresponding target are shown. Note that wild-type and
mutated ISS-N1 element are located within intron 7 of SMN2 and SMN2/64A minigene,
respectively. Arrows mark 10C and 10A positions. The 39-overhang of ASOs are highlighted.
Effect of ASOs on splicing of SMN2 minigene and its mutant, SMN2/64A, is shown in the
bottom panel. Cotransfections and splicing analyses were done as in Figure 2A.
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produced a moderate stimulatory response despite the
unsequestered 10C (Fig. 5C). We observed similar results
using Casp3-SMN59-1 minigene in which 12 residues
between 39-Cluster and ISS-N1 (last three exonic and first
nine intronic residues) were replaced with SMN sequence
(Fig. 5A). The replaced residues combined with the 39-
Cluster and ISS-N1 introduced the 59 ss ‘‘environment’’ of
SMN2 exon 7 in Casp3 minigene. Yet, in Casp3 context the
combination of the unsequestered 10C and L14-duplex was
unable to produce an inhibitory effect observed in SMN2.
These results suggested a possible role of additional se-
quences in conferring the negative effect associated with
unsequestered 10C.
Absence of negative effect of L14 in heterologous context
could be due to the lack of cooperative interactions among
cis-elements that define both, the 39 and 59 ss of SMN2
exon 7. To address this issue, we created a hybrid minigene
(Casp3SMN2) in which we replaced the entire middle exon
and flanking intronic sequences of Casp3 splicing cassette
with 269 nt of SMN2 containing entire exon 7, 116 nt of
upstream intron 6, and 99 nt of downstream intron 7 (Fig.
5D). Thus, Casp3SMN2 provided an opportunity to eval-
uate the effect of F14 and L14 in a ‘‘semi-heterologous’’
system in which large portions of wild-type context de-
fining the 39 and 59 ss of SMN2 exon 7 were present. At the
same time, Casp3SMN2 minigene retained the Casp3
context that defines the 59 ss of upstream and 39 ss of down-
stream exons. As shown in Figure 5D, when Casp3SMN2
was cotransfected with either F14 or L14, both ASOs
promoted exon 7 inclusion. These results indicated that
the inhibitory effect of unsequestered 10C is linked to
FIGURE 4. Effect of the local context on antisense response of ISS-
N1-targeting ASOs. (A) Diagrammatic representation of the target
area in intron 7 of SMN2 minigene and its four mutants. ISS-N1 is
highlighted in gray. The first C residue in ISS-N1 is marked as 10C or
15C, depending on its position relative to the beginning of intron 7. Of
note, numbering of intronic residues starts with the first position of
intron 7. Five-nt-long insertions immediately upstream of ISS-N1 in
SMN2/5A or SMN2/5G minigenes are boxed and shown in capital
letters. (B) In vivo splicing pattern of wild-type and mutant SMN2
minigenes shown in panel A. The minigenes were cotransfected with
an ASO of interest. Cotransfections and splicing analysis were done
similarly as in Figure 2A.
FIGURE 5. Effect of the heterologous context on antisense response
of ISS-N1-targeting ASOs. (A) Diagrammatic representation of exon
6/intron 6 junction in Casp3 minigene variants. 39-Cluster and ISS-
N1, which are shaded in gray, were inserted either individually or
together 3 nt upstream of and 9 nt downstream from the exon/intron
junction, respectively. In Casp3-SMN59-1 minigene, the entire region
from the beginning of 39-Cluster to the end of ISS-N1 corresponds to
SMN sequence. The last 3 nt of SMN exon 7 and the first 9 nt of SMN
intron 7 are highlighted in black. As a result of this insertion, Casp3
exon 6 now has the 59 ss of SMN exon 7 followed by ISS-N1 element.
The location of 10C is marked by an arrow. (B) Effect of 39-Cluster
and ISS-N1 insertions on Casp3 exon 6 splicing. HeLa cells were
transfected with 0.8 mg of Casp3 minigene variant, and the total RNA
for in vivo splicing assay was isolated 24 h post-transfection. Exon
6-included and exon 6-skipped spliced products are indicated. Per-
centage of exon skipping was calculated from the total value of exon-
included and exon-skipped products similarly as in Figure 2. (C) In
vivo splicing patterns of two Casp3 minigene variants in the presence
of ASOs. Cotransfections and splicing analysis were done as in Figure
2A. (D) In vivo splicing patterns of Casp3SMN2 minigene in the
presence of ASOs. Diagram explaining the composition of this hybrid
minigene is shown on the top. Cotransfections and splicing analysis
were done as in panel C.
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a long-distance interaction that could not be formed in the
context of Casp3SMN2. Our results also suggested that the
splicing factors directly interacting with exon 7, and the
flanking intronic sequences are not involved in producing
inhibitory effect associated with unsequestered 10C up-
stream of L14-duplex.
Inhibitory effect of 10C is linked to an intra-intronic
long-distance interaction
Based on the corroborative evidence of experiments de-
scribed in Figures 3–5, the most plausible mechanism of
inhibitory effect of unsequestered 10C would be involve-
ment of a long-distance interaction(s). To explore such pos-
sibility, we generated SMN2 minigene mutants with large
deletions within intron 6 and intron 7 farther away from
the 39 and 59 ss of exon 7. These mutants were then used to
test the effect of F14 and L14 on exon 7 splicing. As shown
in Figure 6, when the 39 portion of intron 7 was deleted
(I7D190-406), the negative effect of L14 on exon 7 splicing
was abrogated and it became almost as effective in restoring
the inclusion of exon 7 as F14. However, in SMN2 mutant
with a deletion in intron 6 (I6D-80-199D), L14 still
retained its inhibitory effect on exon 7 splicing (Fig. 6).
Interestingly, when I6D-80-199D deletion was combined
with I7D190-406 deletion (mutant I6D/I7D), L14 again lost
its inhibitory effect despite the unsequestered 10C (Fig. 6B).
These results are in line with the effect of F14 and L14 on
exon 7 splicing in the hybrid Casp3SMN2 minigene that
lacks similar regions of intron 6 and intron 7 (Fig. 5D). The
observation that L14 lost its ability to increase exon 7
skipping when the region between positions 188 and 407 of
intron 7 was missing provided the first indication of a
potential long-distance interaction between untargeted 10C
and a sequence upstream of the 39 ss of exon 8. In other
words, our results suggest that the inhibitory effect of un-
targeted 10C upstream of L14-duplex is intimately linked to
sequences upstream of the 39 ss of exon 8.
Next we wanted to determine if a specific sequence
upstream of the 39 ss of exon 8 was involved in long-
distance interactions with untargeted 10C. Since the deletion
in the 39 portion of intron 7 that abolished the negative
impact of untargeted 10C in the context of L14-duplex was
rather large (from the 190th and 406th positions), we
generated several SMN2 mutants with smaller overlapping
deletions in this area and cotransfected them with F14 and
L14. Based on the results shown in Figure 7, F14 treatment
effectively restored inclusion of SMN2 exon 7 in all mu-
tants, while the response to L14 appeared to depend upon
size and location of deletion within intron 7. For example,
several sets of overlapping deletions in the 39 region of
intron 7 resulted into the loss of inhibitory effect and/or
gain of stimulatory effect on exon 7 inclusion when the
deletion size was 72 nt or more (Fig. 7). In particular, when
mutants SMN2-I7D195-306 and SMN2-I7D287-393 with
deletions of 112 and 107 nt, respectively, were cotransfected
with L14, exon 7 inclusion increased about 2.5 times
compared with ‘‘mock’’ cotransfection (Fig. 7B). At the
same time, L14 produced no stimulatory effect on mutant
with equally large (115-nt-long) deletion in the 59 portion
of intron 7 (SMN2-I7D30-144) (Fig. 7B). Since ISS-N1
harbors the only target site for L14 within entire SMN2, the
loss of inhibitory effect of L14 in deletion mutants could be
directly linked to the loss of a long-distance interaction
associated with the deleted sequences. Based on our results
we conclude that long-distance interaction is area specific
and not sequence specific. Our results of SMN2 intron 7
deletions do not support a straightforward mechanism of
loss of L14 inhibitory effect as a consequence of the reduced
size of intron 7. Further supporting this argument, a much
larger downstream intron (z1.6 kb) in the heterologous
context of Casp3SMN2 fusion minigene did not recapitu-
late the inhibitory effect of an untargeted 10C upstream of
L14-duplex (Fig. 5D).
Antagonistic effect of ASOs is not linked to the
differential displacement of hnRNP A1
hnRNP A1 motifs located within ISS-N1 have been linked
to skipping of SMN2 exon 7 (Hua et al. 2008). Since F14
and L14 produce an opposite effect on exon 7 splicing, we
wished to test whether these ASOs display any disparity in
their ability to prevent binding of hnRNP A1 to ISS-N1.
FIGURE 6. Effect of deletions within intron 6 and intron 7 on
antisense response of ISS-N1-targeting ASOs. (A) Diagrammatic
representation of the deleted regions in intron 6 and 7 of SMN2
minigene. Deletions are represented by dotted lines. Positive numbers
indicate nucleotide positions within intron 7 and start from the first
position of this intron. Negative numbers indicate nucleotide posi-
tions within intron 6 and start from the last position of this intron.
Names of mutants are given on the left; numbers in names reflect
positions of the first and the last deleted nucleotides. A deletion
mutant producing a stimulatory effect in presence of an ASO is shown
as plus, whereas a mutant producing a negative effect in presence of
an ASO is shown as minus. (B) In vivo splicing pattern of wild-type
and mutant SMN2 minigenes shown in panel A. Minigenes were
cotransfected with an ASO of interest. Cotransfections and splicing
analyses were done similarly as in Figure 2A.
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For this purpose, we performed in vitro experiments using
a purified recombinant hnRNP A1 protein. The purifica-
tion of hnRNP A1 was done using an IMPACT (Intein
Mediated Purification with an Affinity Chitin-binding Tag)
system that allows a single-column purification of an
Escherichia coli expressed protein without vector-derived
amino acids or affinity tags. As shown in the Figure 8A, we
were able to obtain a nearly homogenous (>90% pure)
hnRNP A1 preparation.
We then used site-specific UV-crosslinking to probe the
interaction of the purified hnRNP A1 with ISS-N1. The 50-
nt-long RNA probe used for UV-crosslinking contained the
last 18 residues of exon 7 and the first 32 residues of intron
7 of SMN2, including the ISS-N1 region (Fig. 8B). To
capture a direct interaction of hnRNP A1 with ISS-N1, a
single radioactive 32P-moeity was introduced between the
fifth and the sixth residues of ISS-N1. These residues fall
within the first hnRNP A1 motif of ISS-N1 (Fig. 1A). The
conditions of UV-crosslinking experiments were optimized
to obtain the sufficient amount of hnRNP A1-crosslinked
product following RNase digestion. The results of site-
specific UV-crosslinking confirmed that purified hnRNP A1
binds at the site containing radioactive
moiety (Fig. 8C). Having established that
hnRNP A1 can be site-specifically cross-
linked to ISS-N1, we sought to investi-
gate whether a sequestration of ISS-N1
with F14 or L14 is able to prevent
hnRNP A1 binding. For this purpose,
the site-specifically labeled RNA probe
was denatured and refolded in the pres-
ence of either F14 or L14 prior to
addition of hnRNP A1 and UV cross-
linking. As controls we used the mutant
ASOs, F14comp and L14comp. As de-
scribed earlier, these ASOs produce no
antisense effect due to the mismatch
mutations (Fig. 2). As shown in Figure
8D, F14 and L14 were equally efficient in
preventing the binding of hnRNP A1 to
ISS-N1 as indicated by the substantial
decrease in the amount of hnRNP A1-
crosslinked product compared with ‘‘No
ASO’’ and F14comp/L14comp controls.
In the next experiment, the site-spe-
cifically labeled RNA probe was refolded
prior to addition of the ASOs and
hnRNP A1. Since the ASOs were added
to the reaction mixture after the RNA
probe was refolded, this experiment val-
idated the accessibility of the target un-
der the native conditions. Also it tested
the affinity of hnRNP A1 for its ‘‘native’’
target in the presence of ASOs. Here
again we used F14comp and L14comp as
control ASOs. As shown in Figure 8E, again F14 and L14
were equally efficient in preventing hnRNP A1 binding,
whereas control ASOs had no effect. Our results also
confirmed that sequestration of 10C was not required for
the displacement of hnRNP A1.
DISCUSSION
An untargeted cytosine decides the outcome
of the target-specific antisense response
ISS-N1 has emerged as one of the best-studied intronic
antisense targets for splicing correction in a major human
disease. The 15-nt-long ISS-N1 has the distinction of har-
boring two putative hnRNP A1 motifs covering its last 14
residues (Hua et al. 2008). The first five residues of ISS-N1
together with the three upstream residues constitute an
8-nt-long GC-rich motif (Fig. 1A). Sequestration of either
GC-rich motif or first 14 nt of ISS-N1 has the capability to
fully restore SMN2 exon 7 inclusion in SMA patient cells at
low nanomolar concentrations (Singh et al. 2006, 2009).
Based on these findings, the first five residues of ISS-N1
FIGURE 7. Effect of deletions within intron 7 on antisense response of ISS-N1-targeting
ASOs. (A) Diagrammatic representation of the deleted regions within intron 7 of SMN2
minigene. Deletions are represented by dotted lines. Numbers indicate nucleotide positions
and start from the first position of intron 7. Names of mutants are given on the left; numbers
in the names reflect positions of the first and the last deleted nucleotides. A deletion mutant
producing a stimulatory effect in presence of an ASO is shown as plus, whereas a mutant
producing a negative effect in presence of an ASO is shown as minus. (B) In vivo splicing
pattern of mutant SMN2 minigenes shown in panel A. Minigenes were cotransfected with an
ASO of interest. Cotransfections and splicing analysis were done similarly as in Figure 2A.
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constitute the core of the above two antisense targets
(Singh et al. 2009). Although, the GC-rich sequence is the
shortest known target for effective splicing correction in
a patient cell line, the mechanism by which sequestration
of this sequence restores SMN2 exon 7 inclusion is not
known. Upon annealing to its target, an ASO has a capa-
bility to break the local context by introducing a double
helical structure that affects the orientation of residues up-
stream of and downstream from the helix. Hence, an ASO-
based approach provides a unique opportunity to test the
significance of certain residues at specific positions even
though these positions are not directly targeted by an ASO.
Here we report a rare finding in which an untargeted
cytosine residue at the 10th intronic position (10C) decides
the outcome of the antisense response of ASOs that target
sequences immediately downstream from 10C. A critical
role of 10C was found to stem from its unique location
within the GC-rich motif at a precise distance from the
59 ss of exon 7.
The significance of unsequestered 10C in conferring the
outcome of ISS-N1-targeting ASOs was best captured by
F14 and L14. Targets of F14 and L14 differ by a single
nucleotide. While F14 sequestered 10C and produced an
expected strong stimulatory response on SMN2 exon 7
inclusion, L14 that did not target 10C triggered SMN2 exon
7 skipping. The negative effect of L14 was highly surprising,
since L14 fully sequestered both of the hnRNP A1 motifs.
The opposite effects of F14 and L14 were observed in the
context of both, the endogenous gene and the minigene
containing genomic sequences from SMN2 exon 6 through
exon 8. This confirmed that a specific promoter sequence
and/or any region upstream of exon 6 do not drive the
antisense effect.
To validate the target specificity of F14 and L14, we took
advantage of our meticulously designed mutant minigenes.
In the absence of any off-target effect, it is expected that the
lack of annealing of ASOs with the mutated target would
eliminate the antisense response. Indeed, validating the
target specificity, F14 and L14 lost their ability to affect
exon 7 splicing in the mutated SMN2/I7-08 minigene. In
a counter-experiment, mutant F14 and L14 that reinstated
the base pairing with the mutated ISS-N1 fully restored the
original antisense effects. These results confirmed that the
antisense effects were driven by duplexes formed between
ASOs and their respective intended targets. However, in
case of L14, the inhibitory effect was linked to an untar-
geted 10C since the deletion of 10C reversed the effect of L14
on SMN2 exon 7 splicing (Fig. 3A). Further support for the
inhibitory role of untargeted 10C came from SMN2/64A
mutant in which 10C was replaced by 10A. Since this C-to-A
change did not affect SMN2 exon 7 splicing pattern, 10A
provided an ideal substitution to probe the role of an
untargeted residue immediately upstream of L14-duplex.
L14 was able to fully restore exon 7 inclusion in SMN2/64A.
This surprising result constitutes one of the rare findings in
which a target-specific antisense response was reversed by
an otherwise neutral single nucleotide substitution at the
untargeted position. Our results also confirmed that the
specific location of untargeted 10C upstream of L14-duplex
with respect to the 59 ss is responsible for the inhibitory
effect of L14. Supporting this argument, moving the target
sequence away from the 59 ss significantly decreased the
inhibitory response of L14 (Fig. 4).
Unique antisense response is modulated by
a context-specific long-distance interaction
We used Casp3 minigene containing ISS-N1 to compare the
impact of F14 and L14 in the context of a heterologous
system. We have earlier shown that insertion of ISS-N1
downstream from the 59 ss of Casp3 exon 6 promotes skip-
ping of this exon. As expected, F14 fully restored Casp3
exon 6 inclusion. However, L14 also produced a noticeable
stimulatory response, clearly suggesting that the inhibitory
effect of unsequestered 10C upstream of L14 duplex is not
dependent upon a linear cis-element (Fig. 5). These results
provided the first evidence implicating the role of a long-
distance interaction that is generally hard (if not impossible)
FIGURE 8. (Legend on next page)
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to predict by available algorithms. Our subsequent experi-
ments with a series of deletion mutations in the second half
of intron 7 furnished the strong proof in support of such
interaction (Figs. 6, 7). Our results suggested that an un-
sequestered 10C in presence of L14-duplex interacts with in-
tron 7 sequences upstream of the 39 ss of exon 8. It is con-
ceivable that the annealing of L14 changes the local structure
so that 10C becomes particularly ‘‘accessible’’ for interactions
due to for example flipping. However, further experiments
are required to confirm this possibility. One can hypothesize
that a long-distance interaction with accessible 10C might
interfere with a catalytic core formation at the 59 ss of exon
7. Consequently, the competing 59 ss of exon 6 becomes the
favorable substrate for the transesterification reaction leading
to exon 7 skipping (Fig. 9). On the other hand, 10C se-
questered in F14-duplex would be no longer available for
interactions, leading to usage of the 59 ss of exon 7 (Fig. 9).
Recent updates reaffirm that spliceosome complexes are
massive, dynamic ribonucleoprotein assemblies that un-
dergo extensive remodeling and exchange of components
as spliceosomes are constructed, activated, and recycled
(Smith et al. 2008; Wahl et al. 2009; Newman and Nagai
2010). Prp8 is the largest spliceosomal protein that plays a
significant role in formation of catalytic core of spliceo-
some by establishing contacts with the 59 ss, 39 ss, and
branch point (Grainger and Beggs 2005). It is possible that
specific orientation of untargeted 10C prevents recruitment
of Prp8 and/or its interacting partners that include RNA
helicases with unwinding activity of RNA:RNA duplexes.
Independent reports suggest that the structural rearrange-
ment within spliceosome must release branch point–binding
complexes for the first transesterification reaction to take
place (Golas et al. 2005; Lardelli et al. 2010). Hence, it is
probable that the specific orientation of the untargeted 10C
affects release of the branch point-binding complexes. Role
of specific orientation of the untargeted 10C is somewhat
supported by the observation that 591U-F15 ASO that has a
39 uridine overhang eliminates the inhibitory effect associ-
ated with L14-duplex (Fig. 3B). Since the overhang is po-
sitioned opposite to 10C, one may hypothesize that either
a noncanonical base pairing with 10C partially alters the
orientation of 10C or the overhang sterically shields 10C,
making it inaccessible. As a consequence, the inhibitory
effect of untargeted 10C is reduced. Irrespective of the pos-
sible mechanism, our results clearly indicate that the inhibi-
tory effect of unsequestered 10C is not linked to differential
recruitment of hnRNP A1 to ISS-N1 region since L14 and
F14 were equally efficient in displacing this inhibitory factor
from ISS-N1 (Fig. 8). The discovery of the prominent role of
10C in this study combined with our recent report regarding
splicing modulation by an 8-mer ASO targeting GC-rich
FIGURE 8. Site-specific UV-crosslinking of purified recombinant
hnRNP A1 with ISS-N1. (A) Purification of recombinant hnRNP A1
protein expressed from pTXB3-A1 in E. coli ER2566 strain. Protein
was purified by binding to a chitin affinity column, followed by DTT-
induced self-cleavage of the M. xenopi GyrA intein. Sample aliquots
were collected at different purification steps and used for SDS-
polyacrylamide gel electrophoresis. (Lane 1) Molecular weight
markers; (lane 2) clarified lysate; (lane 3) flow through from the
column; (lanes 4,5) wash with increasing concentration of NaCl; (lane
6) DTT flush; and (lane 7) pooled hnRNP A1-containing fractions
eluted after overnight DTT-induced intein self-cleavage at 4°C. Band
corresponding to hnRNP A1 is indicated by an arrow. Right panel
shows the diagrammatic representation of pTXB3-A1 construct. This
construct contains hnRNP A1 ORF with a C terminus fused in frame
to the M. xenopi GyrA intein/chitin binding domain (CBD). (B)
Diagrammatic representation of steps for site-specific 32P-labeling of
RNA probe. The sequence of probe and its relative location within
SMN are given. ISS-N1 is highlighted in yellow and its sequence
shown in red letters. Position of the 32P-radioisotope incorporation is
indicated by a star. The sequence of the bridging DNA oligonucleotide
is shown in green. (C) Autoradiogram showing hnRNP A1-crosslinked
product. Site-specifically 32P-labeled RNA probe was UV-crosslinked
with purified recombinant hnRNP A1 followed by RNase digestion
and fractionation on 13% SDS-polyacrylamide gel. (D) UV-cross-
linking in the presence of different ASOs under ‘‘denaturing’’
condition. Here, RNA probe was first refolded in the presence of
a corresponding ASO to ensure ASO annealing. After that, the
purified hnRNP A1 was added to the reaction mixture followed by
UV-crosslinking. Analysis of hnRNP A1-crosslinked products was
done as in panel C. (E) UV-crosslinking in the presence of different
ASOs under ‘‘native’’ condition. Here the RNA probe was denatured
and refolded prior to an ASO and hnRNP A1 addition to the reaction
mixture. UV-crosslinking reaction and analysis of the products were
performed as in panel C.
FIGURE 9. Model of SMN2 exon 7 splicing modulation by 10C in the
presence of L14 and F14. (A) L14 pathway: L14 leaves 10C unseques-
tered and accessible for a long-distance interaction with intronic
sequences upstream of the branch point. This arrangement interferes
with the catalytic core formation at the 59 ss of exon 7. Consequently,
the competing 59 ss of exon 6 becomes the favorable substrate for the
transesterification reaction leading to exon 7 skipping. (B) F14
pathway: F14 sequesters 10C and prevents a long-distance interaction
with intronic sequences upstream of the branch point. This arrange-
ment favors catalytic core formation at the 59 ss of exon 7.
Consequently, SMN2 exon 7 inclusion is promoted.
Long-distance interaction in alternative splicing
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sequence, we are tempted to suggest that effect of these ASOs
are realized at least in part due to direct remodeling of
catalytic core and not merely due to displacement of an in-
hibitory factor.
Despite the fact that human U2 introns have no
preference for a particular residue at the 10th intronic po-
sition (Burge et al. 1999), a majority (five out of eight) of
human SMN introns contain C residue at the 10th intronic
position. Four of these 10Cs are also conserved between
human and mice SMN introns. In regard to 10C of ISS-N1,
the entire GC-rich sequence is not conserved between hu-
man and mouse. It remains to be seen if evolutionary pre-
ference for 10Cs in most human SMN introns is merely a
coincidence or a part of a yet to be identified regulatory
network. Although, not all 10C-containing SMN introns are
associated with skipping of exons, it cannot be ruled out
that the specific residues at the 10th intronic position may
augment/delay the process of catalytic core formation and
intron removal. Our finding that the stimulatory effect in
presence of the untargeted 10C was not at par with the
sequestered 10C in all contexts supports this hypothesis.
The number of reported regulatory elements in the
vicinity of the 59 ss of SMN2 exon 7 continues to grow
(Singh 2007b; Hua et al. 2008; Gladman and Chandler
2009). Majority of these cis-elements are absent in mouse
Smn and seem to be specific to humans. Linear cis-elements
and RNA secondary structures define most of these reg-
ulatory elements. Deletions and substitution mutations
have been able to validate the role of all of the SMN cis-
elements described so far. In this study, use of an ASO-
based approach was able to establish the significance of
a single cytosine residue at the 10th intronic position that
falls within a unique GC-rich sequence. Since several of 10C
deletion/substitution mutations did not change the splicing
pattern of SMN2 exon 7 and yet reversed the antisense
response, it became obvious that 10C is an integral part of
the regulatory network involving long-distance and/or
secondary interactions. Role of such interactions have been
implicated in several systems (Bartel et al. 1991; Matsuura
et al. 2001; Singh et al. 2004c). Future experiments would
address the detailed mechanistic aspects that define the very
unique 59 ss of a critical exon, skipping of which is
associated with a major human disease.
MATERIALS AND METHODS
Minigenes and expression vectors
Minigene splicing cassettes pSMN2DI6, SMN2/I7-8, SMN2/5A,
SMN2/5G, N1D30-34, N1D25-34, Casp3Avr, Casp3ISS-N1, and
SMN2/64A were described earlier (Singh et al. 2004b, 2006, 2009).
Mutations, deletions, and insertions within minigenes were in-
troduced by PCR using Phusion High-Fidelity DNA polymerase
(New England Biolabs). Minigene splicing cassettes Casp3-39Cl
and Casp3ISS-N139Cl were generated by inserting TTAAATTAA
sequence in Casp3Avr and Casp3ISS-N1, respectively, using the
AvrII restriction site. The exact locations of TTAAATTAA se-
quence are shown in Figure 5A. In the Casp3-SMN59-1 minigene,
the entire SMN sequence from the 43rd position of exon 7 to 24th
position of intron 7 was inserted in Casp3Avr minigene using
two-step high fidelity PCR as described earlier (Singh et al. 2007).
The same PCR approach was used to generate Casp3SMN2 hybrid
minigene, in which the last 116 residues of intron 5 and the entire
exon 6 of Casp3 were substituted with the last 116 nt of intron 6,
the entire exon 7, and the first 99 nt of intron 7 of SMN2 (Fig.
5D). All minigene constructs were verified by sequencing. All
oligonucleotides for cloning and sequencing were obtained from
Integrated DNA Technologies.
To generate a bacterial expression vector for human hnRNP A1
recombinant protein, hnRNP A1 coding sequence was inserted in
frame with the downstream Mycobacterium xenopi GyrA intein/
chitin binding domain in pTXB3 plasmid (New England Biolabs).
hnRNP A1 sequence was amplified from an hnRNP A1 expression
vector provided by Dr. Benoit Chabot (Universite´ de Sherbrooke)
(LaBranche et al. 1998). For cloning purposes, position 51 in
hnRNP A1 coding sequence was mutated by a two-step PCR
amplification. The 59 portion of hnRNP A1 was amplified with
a pair of primers 59-RNPA-imp2 (GTGGTGGTACCATGGCCTCTA
AGTCAGAGTCTCCTAAAGAGCCCGAACAG)and39-RNPA-Umut
(CCCTCCAATaAAGAGCTTCCTCAGCTGTTCGGGCTC), where
NcoI restriction site is underlined andanA-to-Tmutation at position
51 is indicated by a lowercase letter. This mutation is translationally
silent but destroys a SapI restriction site in a wild-type hnRNP A1.
As a part of our cloning strategy, a GCC codon was added at the
beginning of hnRNP A1 sequence in 59-RNPA-imp2 primer (in-
dicated in italics). This codon helps to create an NcoI restriction
site, which itself [site] contains an ATG sequence used for transla-
tion initiation. To amplify the 39 portion of hnRNP A1 sequence, we
used a pair of primers 59-RNPA-U mut (AGGAAGCTCTTtATTGG
AGGGTTGAGCTTTGAAAC) and 39-RNPA-imp (CTGGTGGTTG
CTCTTCCGCAAAATCTTCTGCCACTGCCATAGCTAC) with an
A-to-T mutation at position 51 indicated by a lowercase letter and
the SapI restriction site underlined. The 39-RNPA-impprimer deletes
the termination codon of hnRNP A1 and introduces the SapI re-
striction site followed by the first codon of M. xenopi GyrA intein
fused to the last codon of hnRNP A1. This primer design guarantees
that after intein-mediated cleavage of the fusion protein (see Protein
Purification Procedure), the recombinant hnRNP A1 will have no
additional amino acids at its C terminus. The 59 and 39 portions
of hnRNP A1 were gel-purified and ligated in the second step PCR
reaction using the primers 59-RNPA-imp2 and 39-RNPA-imp.
The PCR product corresponding to the full-length hnRNP A1 was
gel-purified, digested with NcoI and SapI and cloned between the
corresponding sites of pTXB3 vector. The resulting hnRNP A1
bacterial expression vector, pTXB3-A1, was confirmed by sequenc-
ing. As a result of the cloning strategy, the hnRNP A1 protein ex-
pressed from pTXB3-A1 contains one extra amino acid appended
to the N-terminus.
Cell culture
The E. coli strain ER2566 (New England Biolabs) was used for
expression of the recombinant hnRNP A1 protein. The strain
was grown in LB medium supplemented with 100 mg/mL of am-
picillin. HeLa cells obtained from the American Type Culture
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Collection were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS).
Primary fibroblast cell line from SMA type I patient (repository
no. GM03813) was obtained from Coriell Cell Repositories. These
cells were maintained in MEM supplemented with 2 mM
GlutaMAX-I and 15% FBS. All tissue culture media and supple-
ments were purchased from Invitrogen.
Antisense oligonucleotides
RNA ASOs were synthesized by Dharmacon Inc. or by TriLink
Biotechnologies. ASOs incorporated 29-O-methyl modification
and phosphorothioate backbone (2OMePS) as described earlier
(Singh et al. 2006). LNAs containing uniform phosphorothioate
backbone were synthesized by Exiqon.
Transfections and in vivo splicing assays
Transient transfections of cells with plasmid DNA and/or with
ASOs were performed using Lipofectamine 2000 (Invitrogen)
following the manufacturer’s recommendations. Briefly, cells were
plated 24 h prior to transfection so that their density on the day of
transfection wasz80%. Oligonucleotide concentration varied and
is specified in the legends of Figures 1 and 2. Depending on the
experiment, the amount of the plasmid used for transfection was
either 0.1 or 0.8 mg. In a given experiment, the total amount of
ASO was maintained constant by adding the control oligonucleo-
tide (59-UUGCCUUUCU-39). The transfection efficiency of an
ASO was measured in a parallel experiment with the fluorescent
labeled control ASO along with the experimental ASO. Total RNA
was isolated at the indicated time points using Trizol reagent
(Invitrogen). To generate cDNA, reverse-transcription was carried
out using SuperScript III Reverse Transcriptase (Invitrogen) and
Oligo (dT) primer (Invitrogen). Minigene-specific spliced prod-
ucts were identified using Taq DNA polymerase (Invitrogen) and
the following pairs of primers: P1 and P2 for SMN2 minigene
(Singh et al. 2004b), P1 and P56 for Casp3Avr-based minigenes
(Singh et al. 2006), and N-24 and P2 for endogenous SMN (Singh
et al. 2006). PCR reactions were performed in the presence of
a trace amount of [a-32P] dATP (3000 Ci/mmol, Perkin-Elmer).
Analysis and quantifications of spliced products were performed
using a FPL-5000 Image Reader and Multi Gauge software (Fuji
Photo Film Inc.). Results were confirmed by at least three
independent experiments. Standard deviation was less than 5%
of the mean.
Purification of hnRNP A1 protein
E. coli ER2566 was transformed with pTXB3-A1 expression
plasmid and plated on LB-agar plates containing ampicillin. A
single freshly grown colony from the LB plate was inoculated into
5 mL of LB medium with ampicillin and grown overnight at 37°C.
The entire 5 mL of the overnight culture was then used to in-
oculate 500 mL of fresh LB medium with ampicillin, and bacterial
growth continued until the OD600 of the culture reached 0.8. At
this moment, the culture was shifted to 30°C, and the protein
expression was induced with 0.2 mM IPTG for 5 h. All subsequent
steps were carried out at 4°C. The cells were harvested by cen-
trifugation at 6000 rpm for 10 min (Sorvall Legend RT+
centrifuge, Thermo Scientific), and the cell pellet was resuspended
in 10 mL of ice-cold column buffer (CB; 20 mM Na-HEPES at pH
8.5, 1 mM EDTA, 500 mM NaCl) supplemented with Protease
Inhibitor Cocktail (Roche). Cells were lysed by sonication on ice
at 5 W for five 10-sec bursts, with 60-sec intervals (Microson Ultra
sonic cell disruptor, Misonix Inc.) followed by centrifugation at
12,000 rpm for 15 min to remove cell debris. For affinity chro-
matography, the lysate was diluted to 50 mL with ice-cold CB and
slowly loaded on a chitin (New England Biolabs) column (Bio-
Rad; 10 mL plastic column with a 5 mL bed volume) equilibrated
at 4°C with 50 mL of CB. The column was then washed with 100
mL of CB, followed by another wash with 50 mL of CB, in which
NaCl concentration was increased from 500 to 700 mM. The
hnRNP A1 protein was released by inducing an on-column intein
self-cleavage in the presence of DTT. To induce intein self-
cleavage, the column was quickly flushed with 15 mL of CB
containing 50 mM DTT. The column flow was stopped, and the
column was left overnight at 4°C. The freed hnRNP A1 protein
was eluted from the column with CB. Elution fractions of 1 mL
were collected, and the hnRNP A1 protein was recovered in the
first nine fractions. The pooled fractions were desalted using NAP
columns (GE Healthcare) and stored in 50% glycerol at 80°C.
The eluted protein was analyzed by electrophoresis in 10% SDS-
polyacrylamide gels, stained with Coomassie blue. Protein con-
centration was determined against BSA standards run on a SDS-
polyacrylamide gel.
Generation of site-specifically labeled RNA probe
All synthetic RNA oligonucleotides used to generate a site-
specifically 32P-labeled probe were obtained from Dharmacon.
The 39 portion of the probe, 5DN-18 (AUUAUGAAAGUGAAU
CUU), was 59-end-labeled using [g-32P] ATP (3000 Ci/mmole,
Perkin-Elmer) and T4 polynucleotide kinase (New England
Biolabs) followed by phenol:chloroform extraction and ethanol
precipitation. The 59-end-labeled 5DN-18 fragment was then
ligated to the 59 portion of the probe, TSL2-U1-32 (CAUUCCUU
AAAUUAAGGAGUAAGUCUGCCAGC) using T4 DNA ligase
(New England Biolabs) and a bridging DNA oligonucleotide
(GGAATTTAATTCCTCATTCAGACGGTCGTAATACTTTCAC).
The bridging oligonucleotide was complementary to 28- and 12-
nt-long segments on the 59 and 39 portions of the probe, re-
spectively (Fig. 8B). Briefly, two RNA fragments were hybridized
to the bridging DNA by mixing 50 pmol of 5DN-18, 50 pmol
TSL2-U1-32, and 100 pmol of bridging DNA and 2 mL 103 DNA
ligation buffer (New England Biolabs) in a 16 mL reaction
mixture. The mixture was heated for 2 min at 75°C and shifted
to 37°C. At this point 20 units of Superase (Ambion) was added to
the reaction mixture, and the incubation proceeded for 3 h. The
hybridized substrates were then ligated by adding 20 nmol of ATP
and 400 units of T4 DNA ligase (New England Biolabs). The
ligation was carried out for 4 h at 37°C. The ligated RNA product
was gel purified in a denaturing 16% polyacrylamide gel contain-
ing 8 M urea. The RNA product was eluted overnight at 37°C
using the ‘‘crush and soak’’ method (Singh et al. 2006) and pre-
cipitated with ethanol.
UV-crosslinking
For UV-crosslinking under native condition, the site-specifically
32P-labeled RNA probe was first denatured for 3 min at 90°C and
refolded for 1 h at 37°C. Fifty nanograms of the refolded probe
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was then used in a 50 mL crosslinking reaction containing 20 mM
Tris-Cl (pH 7.6), 200 mM KCl, and 2 mM MgCl2. When needed,
0.6 mM of an ASO of interest was used in crosslinking reaction.
Initial experiments were done in native condition in which RNA
probe was first refolded by heating for 3 min at 90°C followed by
slow cooling to room temperature. Next, refolded RNA probe and
the ASO were incubated for 1 h at 37°C before 2.5 mg of hnRNP
A1 was added; the reaction was then moved to ambient temper-
ature, and the incubation continued for another 10 min. The
UV-crosslinking of RNA–protein complexes was carried out on
ice at a distance of 0.5 cm for 15 min using a hand-held UV-
transilluminator (254 nm, UVG 54, UVP). After crosslinking, the
RNA was digested with 1 unit of RNase T1 (USB) and 1 mg RNase
A (TEKnova) for 30 min at 37°C. The crosslinked products were
resolved by electrophoresis on a 13% SDS-polyacrylamide gel,
which was then dried and analyzed using a FPL-5000 Image
Reader (Fuji Photo Film Inc.).
For UV-crosslinking under denaturing condition, 50 ng of the
RNA probe was added to a 50 mL crosslinking reaction containing
20 mM Tris-HCl (pH 7.6), 200 mM KCl, and 2 mM MgCl2 with
or without 0.6 mM ASO. The reaction mixture was heated for
3 min to 90°C and moved to 37°C for an overnight incubation.
This refolding of the RNA and an ASO together ensures that the
latter will anneal to its target sequence. Following the overnight
incubation, 2.5 mg of hnRNP A1 was added to the reaction, and it
was shifted to an ambient temperature for 10 min. UV-crosslinking
and detection of RNA-hnRNP A1 crosslinked products were done
similarly as described for ‘‘native’’ conditions.
ACKNOWLEDGMENTS
We thank Drs. Benoit Chabot and Peter Mouritzen for providing
hnRNP A1 expression vector and for providing help with design
of LNAs, respectively. This work was supported by a grant from
United States National Institutes of Health (R01NS055925) to
R.N.S. R.N.S. acknowledges support from a Salsbury Endowment
at Iowa State University. N.N.S. is supported in part by the Center
for Integrated Animal Genomics at Iowa State University. R.N.S.
and N.N.S. are also supported in part by the Iowa Center for
Advanced Neurotoxicology.
Received March 1, 2010; accepted March 12, 2010.
REFERENCES
Bartel DP, Zapp ML, Green MR, Szostak JW. 1991. HIV-1 Rev
regulation involves recognition of non-Watson–Crick base pairs in
viral RNA. Cell 67: 529–536.
Bauman J, Jearawiriyapaisarn N, Kole R. 2009. Therapeutic potential
of splice-switching oligonucleotides. Oligonucleotides 19: 1–14.
Buratti E, Baralle M, Baralle FE. 2006. Defective splicing, disease and
therapy: Searching for master checkpoints in exon definition.
Nucleic Acids Res 34: 3494–3510.
Buratti E, Dhir A, Lewandowska MA, Baralle FE. 2007. RNA structure
is a key regulatory element in pathological ATM and CFTR
pseudoexon inclusion events. Nucleic Acids Res 35: 4369–4383.
Burge CB, Tuschl T, Sharp PA. 1999. Splicing of precursors to mRNAs
by the spliceosomes. In The RNA world (ed. RF Gesteland et al.),
2nd ed., pp. 525–560. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY.
Chasin LA. 2007. Searching for splicing motifs. Adv Exp Med Biol 623:
85–106.
Cooper TA, Wan L, Dreyfuss G. 2009. RNA and disease. Cell 136:
777–793.
David CJ, Manley JL. 2008. The search for alternative splicing
regulators: New approaches offer a path to a splicing code. Genes
Dev 22: 279–285.
Garcia-Blanco MA. 2006. Alternative splicing: Therapeutic target and
tool. Prog Mol Subcell Biol 44: 47–64.
Gladman JT, Chandler DS. 2009. Intron 7 conserved sequence
elements regulate the splicing of the SMN genes. Hum Genet
126: 833–841.
Golas MM, Sander B, Will CL, Lu¨hrmann R, Stark H. 2005. Major
conformational change in the complex SF3b upon integration into
the spliceosomal U11/U12 di-snRNP as revealed by electron
cryomicroscopy. Mol Cell 17: 869–883.
Graveley BR. 2005. Mutually exclusive splicing of the insect Dscam
pre-mRNA directed by competing intronic RNA secondary struc-
tures. Cell 123: 65–73.
Grainger RJ, Beggs JD. 2005. Prp8 protein: At the heart of the
spliceosome. RNA 11: 533–557.
Hertel KJ. 2008. Combinatorial control of exon recognition. J Biol
Chem 283: 1211–1215.
HuaY,VickersTA,OkunolaHL,BennettCF,KrainerAR. 2008.Antisense
masking of an hnRNPA1/A2 intronic splicing silencer corrects SMN2
splicing in transgenic mice. Am J Hum Genet 82: 834–848.
LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ,
Chabot B. 1998. Telomere elongation by hnRNP A1 and a de-
rivative that interacts with telomeric repeats and telomerase. Nat
Genet 19: 199–202.
Lardelli RM, Thompson JX, Yates JR 3rd, Stevens SW. 2010. Release
of SF3 from the intron branchpoint activates the first step of pre-
mRNA splicing. RNA 16: 516–528.
Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L,
Benichou B, Cruaud C, Millasseau P, Zeviani M, et al. 1995.
Identification and characterization of a spinal muscular atrophy-
determining gene. Cell 80: 1–5.
Lin S, Fu XD. 2007. SR proteins and related factors in alternative
splicing. Adv Exp Med Biol 623: 107–122.
Martinez-Contreras R, Cloutier P, Shkreta L, Fisette JF, Revil T,
Chabot B. 2007. hnRNP proteins and splicing control. Adv Exp
Med Biol 623: 123–147.
Matlin AJ, Moore MJ. 2007. Spliceosome assembly and composition.
Adv Exp Med Biol 623: 14–35.
Matsuura M, Noah JW, Lambowitz AM. 2001. Mechanism of maturase-
promoted group II intron splicing. EMBO J 20: 7259–7270.
Newman AJ, Nagai K. 2010. Structural studies of the spliceosome:
Blind men and an elephant. Curr Opin Struct Biol 20: 82–89.
Nilsen TW. 2003. The spliceosome: The most complex macromolec-
ular machine in the cell. Bioessays 25: 1147–1149.
Nilsen TW, Graveley BR. 2010. Expansion of eukaryotic proteome by
alternative splicing. Nature 463: 457–463.
Ooms M, Verhoef K, Southern E, Huthoff H, Berkhout B. 2004.
Probing alternative foldings of the HIV-1 leader RNA by antisense
oligonucleotide scanning arrays. Nucleic Acids Res 32: 819–827.
Shepard PJ, Hertel KJ. 2008. Conserved RNA secondary structures
promote alternative splicing. RNA 14: 1463–1469.
Singh RN. 2007a. Unfolding the mystery of alternative splicing
through a unique method of in vivo selection. Front Biosci 12:
3263–3272.
Singh RN. 2007b. Evolving concepts on human SMN pre-mRNA
splicing. RNA Biol 4: 7–10.
Singh NN, Androphy EJ, Singh RN. 2004a. The regulation and
regulatory activities of alternative splicing of the SMN gene. Crit
Rev Eukaryot Gene Expr 14: 271–285.
Singh NN, Androphy EJ, Singh RN. 2004b. An extended inhibitory
context causes skipping of exon 7 of SMN2 in spinal muscular
atrophy. Biochem Biophys Res Commun 315: 381–388.
Singh NN, Androphy EJ, Singh RN. 2004c. In vivo selection reveals
combinatorial controls that define a critical exon in the spinal
muscular atrophy genes. RNA 10: 1291–1305.
Singh et al.
1180 RNA, Vol. 16, No. 6
 Cold Spring Harbor Laboratory Press on January 26, 2016 - Published by rnajournal.cshlp.orgDownloaded from 
Singh NK, Singh NN, Androphy EJ, Singh RN. 2006. Splicing of
a critical exon of human Survival Motor Neuron is regulated by
a unique silencer element located in the last intron. Mol Cell Biol
26: 1333–1346.
Singh NN, Singh RN, Androphy EJ. 2007. Modulating role of RNA
structure in alternative splicing of a critical exon in the spinal
muscular atrophy genes. Nucleic Acids Res 35: 371–389.
Singh NN, Shishimorova M, Cao LC, Gangwani L, Singh RN. 2009. A
short antisense oligonucleotide masking a unique intronic motif
prevents skipping of a critical exon in spinal muscular atrophy.
RNA Biol 6: 341–350.
Smith DJ, Query CC, Konarska MM. 2008. ‘Nought may endure but
mutability’: Spliceosome dynamics and the regulation of splicing.
Mol Cell 30: 657–666.
Tazi J, Bakkour N, Stamm S. 2009. Alternative splicing and disease.
Biochim Biophys Acta 1792: 14–26.
Veedu RN, Wengel J. 2009. Locked nucleic acid as a novel class of
therapeutic agents. RNA Biol 6: 321–323.
Vitte J, Fassier C, Tiziano FD, Dalard C, Soave S, Roblot N, Brahe C,
Saugier-Veber P, Bonnefont JP, Melki J. 2007. Refined character-
ization of the expression and stability of the SMN gene products.
Am J Pathol 171: 1269–1280.
Wahl MC, Will CL, Lu¨hrmann R. 2009. The spliceosome: Design
principles of a dynamic RNP machine. Cell 136: 701–718.
Wang Z, Burge CB. 2008. Splicing regulation: From a parts list of
regulatory elements to an integrated splicing code. RNA 14: 802–
813.
Ward AJ, Cooper TA. 2010. The pathology of splicing. J Pathol 220:
152–163.
Warf MB, Diegel JV, von Hippel PH, Berglund JA. 2009. The protein
factors MBNL1 and U2AF65 bind alternative RNA structures to
regulate splicing. Proc Natl Acad Sci 106: 9203–9208.
Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK,
Lutz GJ. 2009. Oligonucleotide-mediated survival of motor neu-
ron protein expression in CNS improves phenotype in a mouse
model of spinal muscular atrophy. J Neurosci 29: 7633–7638.
Wirth B, Brichta L, Hahnen E. 2006. Spinal muscular atrophy and
therapeutic prospects. Prog Mol Subcell Biol 44: 109–132.
Xing Y, Lee C. 2007. Relating alternative splicing to proteome
complexity and genome evolution. Adv Exp Med Biol 623: 36–49.
Yu Y, Maroney PA, Denker JA, Zhang XH, Dybkov O, Lu¨hrmann R,
Jankowsky E, Chasin LA, Nilsen TW. 2008. Dynamic regulation of
alternative splicing by silencers that modulate 59 splice site
competition. Cell 135: 1224–1236.
Long-distance interaction in alternative splicing
www.rnajournal.org 1181
 Cold Spring Harbor Laboratory Press on January 26, 2016 - Published by rnajournal.cshlp.orgDownloaded from 
 10.1261/rna.2154310Access the most recent version at doi:
 2010 16: 1167-1181 originally published online April 22, 2010RNA
  
Natalia N. Singh, Katrin Hollinger, Dhruva Bhattacharya, et al. 
  
linked to a unique long-distance interaction in pre-mRNA splicing
An antisense microwalk reveals critical role of an intronic position
  
References
  
 http://rnajournal.cshlp.org/content/16/6/1167.full.html#ref-list-1
This article cites 46 articles, 15 of which can be accessed free at:
Service
Email Alerting
  
 click here.right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the top
 http://rnajournal.cshlp.org/subscriptions
 go to: RNATo subscribe to 
Copyright © 2010 RNA Society
 Cold Spring Harbor Laboratory Press on January 26, 2016 - Published by rnajournal.cshlp.orgDownloaded from 
